Total Payments
$511,301
2024 Payments
$107,637
Companies
44
Transactions
773
Medicare Patients
6,949
Medicare Billing
$2.3M
Payment Breakdown by Category
Consulting$203,304 (39.8%)
Other$146,078 (28.6%)
Research$96,312 (18.8%)
Travel$41,158 (8.0%)
Food & Beverage$23,617 (4.6%)
Gifts$687.67 (0.1%)
Education$144.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $203,304 | 68 | 39.8% |
| Unspecified | $96,312 | 14 | 18.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $77,733 | 18 | 15.2% |
| Honoraria | $43,950 | 17 | 8.6% |
| Travel and Lodging | $41,158 | 111 | 8.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $24,395 | 5 | 4.8% |
| Food and Beverage | $23,617 | 534 | 4.6% |
| Gift | $687.67 | 3 | 0.1% |
| Education | $144.00 | 3 | 0.0% |
Payments by Type
General
$414,989
759 transactions
Research
$96,312
14 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Endo Pharmaceuticals Inc. | $108,492 | 52 | $0 (2022) |
| STRATA Skin Sciences, Inc. | $52,985 | 13 | $0 (2023) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $44,357 | 94 | $0 (2024) |
| MERZ NORTH AMERICA, INC. | $44,267 | 87 | $0 (2024) |
| VYNE Pharmaceuticals Inc. | $39,721 | 37 | $0 (2021) |
| Arcutis Biotherapeutics, Inc. | $37,471 | 35 | $0 (2024) |
| Medline Industries, Inc. | $36,512 | 41 | $0 (2021) |
| MIMEDX Group, Inc. | $32,920 | 15 | $0 (2024) |
| PFIZER INC. | $23,424 | 33 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $19,237 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $107,637 | 137 | MIMEDX Group, Inc. ($32,920) |
| 2023 | $80,525 | 80 | STRATA Skin Sciences, Inc. ($52,950) |
| 2022 | $59,125 | 45 | Endo Pharmaceuticals Inc. ($54,174) |
| 2021 | $26,015 | 79 | VYNE Pharmaceuticals Inc. ($20,085) |
| 2020 | $51,648 | 57 | Endo Pharmaceuticals Inc. ($24,610) |
| 2019 | $68,983 | 151 | Ortho Dermatologics, a division of Bausch Health US, LLC ($23,509) |
| 2018 | $44,650 | 108 | Ortho Dermatologics, a division of Bausch Health US, LLC ($15,490) |
| 2017 | $72,718 | 116 | MERZ NORTH AMERICA, INC. ($32,768) |
All Payment Transactions
773 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $8,029.00 | General |
| Category: ONCOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $4,588.00 | General |
| Category: ONCOLOGY | ||||||
| 12/20/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $1,147.00 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $3.85 | General |
| Category: Immunology | ||||||
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.57 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Travel and Lodging | In-kind items and services | $461.35 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $105.90 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $97.89 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $76.40 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $39.41 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $39.41 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2024 | Regeneron Pharmaceuticals, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $35.52 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $42.07 | General |
| Category: Immunology | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: FACIAL AESTHETICS | ||||||
| 12/04/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Consulting Fee | Cash or cash equivalent | $3,375.00 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: Immunology | ||||||
| 12/02/2024 | MIMEDX Group, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,125.00 | General |
| 12/02/2024 | MIMEDX Group, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,437.50 | General |
| 12/02/2024 | MIMEDX Group, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| 12/02/2024 | MIMEDX Group, Inc. | — | Travel and Lodging | Cash or cash equivalent | $189.38 | General |
| 12/02/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $43.72 | General |
| Category: Immunology | ||||||
| 12/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.55 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Solta Medical, a division of Bausch Health US, LLC | THERMAGE FLX | Consulting Fee | Cash or cash equivalent | $6,960.00 | General |
| 11/25/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Consulting Fee | Cash or cash equivalent | $2,625.00 | General |
| Category: Dermatology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 2B, Open-Label Study to Explore Tissue Histopathology Following Subcutaneous Injection of Collagenase Clostridium Histolyticum Using An Abdominoplasty Model | Endo Pharmaceuticals Inc. | $54,145 | 2 |
| Not Specific to one study | Endo Pharmaceuticals Inc. | $39,781 | 11 |
| EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSO) | Eli Lilly and Company | $2,387 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,879 | 2,712 | $2.3M | $618,512 |
| 2022 | 25 | 1,792 | 2,429 | $2.3M | $621,099 |
| 2021 | 26 | 1,889 | 2,598 | $2.3M | $657,055 |
| 2020 | 23 | 1,389 | 2,223 | $1.5M | $412,101 |
Total Patients
6,949
Total Services
9,962
Medicare Billing
$2.3M
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 5 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 15271 | Application of skin substitute (wound surface up to 100 sq cm) to trunk, arms, or legs (first 25 sq cm or less) | Office | 2020 | 15 | 15 | $6,271 | $987.06 | 15.7% |
About Dr. Ashish Bhatia, M.D
Dr. Ashish Bhatia, M.D is a Dermatology healthcare provider based in Itasca, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/18/2005. The National Provider Identifier (NPI) number assigned to this provider is 1073595690.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashish Bhatia, M.D has received a total of $511,301 in payments from pharmaceutical and medical device companies, with $107,637 received in 2024. These payments were reported across 773 transactions from 44 companies. The most common payment nature is "Consulting Fee" ($203,304).
As a Medicare-enrolled provider, Bhatia has provided services to 6,949 Medicare beneficiaries, totaling 9,962 services with total Medicare billing of $2.3M. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties MOHS-Micrographic Surgery, Procedural Dermatology
- Location Itasca, IL
- Active Since 11/18/2005
- Last Updated 02/25/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1073595690
Products in Payments
- XTRAC (Device) $52,985
- Zoryve (Drug) $26,808
- AMZEEQ (Drug) $25,497
- CIBINQO (Drug) $20,982
- LIBTAYO (Biological) $19,268
- ALTRENO (Drug) $19,120
- ZILXI (Drug) $14,224
- SILIQ (Drug) $12,531
- THERMAGE FLX $7,389
- QBREXZA (Drug) $6,072
- CELLUTOME (Device) $5,742
- KYBELLA (Biological) $4,560
- RETIN-A-MICRO (Drug) $4,458
- ARAZLO (Drug) $2,800
- TALTZ (Drug) $2,727
- RHOFADE (Drug) $2,397
- EUCRISA (Drug) $1,997
- BOTOX COSMETIC (Biological) $1,837
- Dermatology and Wound Care (Medical Supply) $1,679
- XEOMIN (Biological) $1,299
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.